Zeo ScientifiX, Inc. (ZEOX) Form 10-Q — Jun 15, 2026
Zeo ScientifiX reported revenue of $4.03 million for the six months ended April 30, 2026, representing an 80% increase year-over-year, driven by sales of higher concentration allogenic biologic products. Despite this revenue growth, the company incurred a net loss of $997,000 and utilized $609,000 in cash from operating activities during the period. The company highlighted severe financial risks, disclosing substantial doubt about its ability to continue as a going concern for the next twelve months.
Key figures
- Revenue
- 4027000
- Cash Position
- 1846000
- Shares Outstanding
- 7787441
- Working capital
- 155000
- Subsequent event proceeds
- 200000
- Private placement proceeds 6 months
- 1850000
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.